METASTATIC MALIGNANT NEOPLASM IN THE BONE
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE BONE trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug shows promise for Hard-to-Treat prostate cancer
Disease control TerminatedThis phase 2 study tested the drug erdafitinib in 11 men with castration-resistant prostate cancer that had spread to the bone. The goal was to see if the drug could slow the cancer and to study bone and blood markers. The trial was terminated early, so results are limited.
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Radioactive treatment for bone pain in advanced prostate cancer tested, but study stopped early
Symptom relief TerminatedThis study tested a radioactive drug called Sn-117m-DTPA to see if it could reduce bone pain in men with prostate cancer that had spread to their bones and no longer responded to hormone therapy. Only one person enrolled before the study was stopped. The goal was to measure pain …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC